Fig 3.

Association of disease severity with the magnitude of liver tests abnormalities.

(A) Stacked graphs presenting the percentage of patients that either achieved or not achieved (others) the endpoint of either mechanical ventilation or death or death only, as a function of their liver tests (ALT and AST <40 IU/L, at least 1 of the enzymes ≥40 IU/L but <200 IU/L or at least one of the enzymes ≥200 IU/L) for influenza or SARS-CoV-2 infections (∗p <0.001). (B) Median values and range (upper/lower limits) of liver enzymes for patients that either achieved or not (others) the composite endpoint (mechanical ventilation or death or death only) for influenza or SARS-CoV-2 infections (∗p <0.001). ALT, alanine transaminase; AST, aspartate transaminase; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.